BMO Capital Markets’s $220 target on BIIB

BIIB Biogen

$229 → $220 (-4%) by Oct 2027

Market Perform · raises · said Oct 12, 2026 · 12-month default horizon

Open: judged on the close on Oct 12, 2027

The article this target came from

BMO raises Biogen stock price target on turnaround strength

Investing.com · Oct 12, 2026

raised its price target on Biogen Inc. (NASDAQ:BIIB) to $220 from $218

BMO Capital Markets’s track record → Biogen →

A fact about what BMO Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; BMO Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.